Results 1 to 10 of about 48,636 (289)
Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
Research and Practice in Thrombosis and Haemostasis, 2022 Background Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded)
Emmanuel J Favaloro, Leonardo Pasalic
exaly +4 more sources
A Study of Using Anticoagulants in a Tertiary Care Hospital in Bangalore: A Prospective Study [PDF]
Journal of Health Sciences and Surveillance System, 2021 Background: drug utilization studies are necessary to evaluate the rational use and associated risks of anticoagulants. This study aimed to identify drug utilization pattern and possible drug interactions with the use of anticoagulants in a tertiary care
Shahrzad Raouf +3 more
doaj +1 more source
Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022 A post-COVID patient with a high D-dimer Value (>5000 IU) was posted for total knee replacement. She was on multiple anticoagulants including the novel oral anticoagulants that started to reduce thrombotic risk.
Balasubramaniam Gayathri +3 more
doaj +1 more source
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
Российский кардиологический журнал, 2021 The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj +1 more source
IMPACT OF NON-VITAMIN K ORAL ANTI-COAGULANTS ON WARFARIN UTILISATION AND NHS BUDGET IN UK
Global Journal of Public Health Medicine, 2022 Introduction: Vitamin K anticoagulants were the mainstay prophylaxis of stroke in patients with atrial fibrillation and thromboembolic diseases. Non-vitamin K oral anticoagulants were approved for use in UK.
Mohammed Aladul +2 more
doaj +1 more source
Reviews in Cardiovascular Medicine, 2022 After reading with great interest the article entitled: “Non-vitamin K antagonist oral anticoagulants (NOACs) do not increase the risk of hepatic impairment in patients with non-valvular atrial fibrillation: insights from multi-source medical data ...
Aleksandr Urakov +4 more
doaj +1 more source
Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
Cells, 2022 Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent) venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a century, and, nowadays, physicians possess a broad panel of multiple ...
Marco Heestermans +4 more
doaj +1 more source
Antiviral anticoagulation [PDF]
Research and Practice in Thrombosis and Haemostasis, 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel envelope virus that causes coronavirus disease 2019 (COVID-19). Hallmarks of COVID-19 are a puzzling form of thrombophilia that has elevated D-dimer but only modest effects on other parameters of coagulopathy.
Pryzdial, Edward L. G. +3 more
openaire +3 more sources
Journal of Pharmaceutical Policy and Practice, 2021 Background Anticoagulants are the cornerstone therapy for the management of venous thromboembolism (VTE) and atrial fibrillation (AF). Pharmacists should be confident and equipped with the skill and updated knowledge in managing anticoagulation therapy ...
Sze Ling Tan +4 more
doaj +1 more source
Annals of Medicine, 2022 Background Literature suggests that different risks of mortality could influence physicians in prescribing or not anticoagulants in older patients with atrial fibrillation (AF). The Multidimensional Prognostic Index (MPI) can be considered a tool for the
Alberto Pilotto +7 more
doaj +1 more source